making news with our
portfolio companies
Drive DeVilbiss Healthcare Acquires Product Line of De Oro Devices, Makers of NexStride® Gait-Cueing Device
The acquisition of De Oro Devices expands access to research-backed technology that helps people with neuroambulatory disorders stay active and reduce fall risk.
Published FDA Pivotal Studies Find DermaSensor has 96% Sensitivity and Cuts Physician’s Missed Skin Cancers by Half
Published in the Journal of Primary Care and Community Health, the joint FDA pivotal studies demonstrated the performance and benefits of the hand-held, non-invasive, optical spectroscopy device in point-of-care skin lesion evaluation.
MIMOSA Diagnostics completes latest raise to accelerate north american commercialization
MIMOSA Diagnostics raises additional funds to support continued commercialization and growth.
New technology introduced to help Parkinson's patients walk
80% of Parkinson's patients suffer from a symptom called "freezing of gait." It’s when people suddenly lose the ability to take a step.